Comments submitted regarding Clinical Outcome Assessment Compendium. (Docket number:FDA-2015-N-5106). Click here to read the comments and impact on ACRP Members.
Remote monitoring is here to stay, says Sandra SAM Sather, MS, BSN, CCRC, CCRA, vice president at Clinical Pathways, LLC. That said, she wonders if it increases the burden on research sites to de-identify subjects’ medical records. She notes that, in many cases today, it does increase that burden and often blocks access remotely to […]
Powerful forces of change are transforming the clinical trials landscape—and that’s a good thing, says Ken Getz, director of sponsored research and associate professor at the Tufts Center for the Study of Drug Development and founder of CenterWatch. “It’s exciting but also daunting, because it forces us to confront and consider” structural and operating changes […]
Clinical trial billing errors continue to emerge at established, well-respected sites—and the penalties and publicity can hit hard, warns Brent Ibata, PhD, JD, MPH, FACHE, RAC, CCRC, CPI, CHRC, the research compliance officer at Sentara Healthcare. It is rarely a case of out-and-out fraud, Ibata notes. Instead, it can be a lack of understanding. Clinical […]
As an accomplished motivational speaker, it would be pretty easy for classical violinist Kai Kight to stick with the same presentation over and over. However, that’s not how he rolls. “I’m nervous before every talk because I try new things all the time,” he says. Something’s obviously working: He was just named one of the […]
